US Clinical Research Organization Selects OmniComm To Provide EClinical Solutions

OmniComm Systems has reported that a US Clinical Research Organization (CRO) has selected OmniComm to provide eClinical solutions, in connection with two of the CRO’s phase IV studies.

Cornelis Wit, president and CEO of OmniComm, said: We are pleased to have been selected by this CRO to provide eClinical solutions for these important Phase IV studies.

We believe the broad scope of our integrated eClinical solutions, enhanced by the recent acquisition of eResearch Technology’s data capture unit, positions us well to offer a broad array of solutions, especially for CRO’s, pharmaceutical, biotech and medical device companies seeking cost-effective tools to capture and track outcomes of clinical trials conducted at multiple locations. We look forward to expanding the range of services we provide for companies seeking to increase efficiencies in their clinical activities, he added.